SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-15-000913
Filing Date
2015-03-16
Accepted
2015-03-16 11:42:30
Documents
20
Period of Report
2015-03-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vsta8k_mar162015.htm 8-K 22273
2 INVESTOR PRESENTATION ex99-1.htm EX-99.1 14513
3 vstamar2015_01.jpg GRAPHIC 35774
4 vstamar2015_02.jpg GRAPHIC 104841
5 vstamar2015_03.jpg GRAPHIC 52092
6 vstamar2015_04.jpg GRAPHIC 50830
7 vstamar2015_05.jpg GRAPHIC 37452
8 vstamar2015_06.jpg GRAPHIC 61571
9 vstamar2015_07.jpg GRAPHIC 65221
10 vstamar2015_08.jpg GRAPHIC 70143
11 vstamar2015_09.jpg GRAPHIC 62742
12 vstamar2015_10.jpg GRAPHIC 63741
13 vstamar2015_11.jpg GRAPHIC 54374
14 vstamar2015_12.jpg GRAPHIC 56716
15 vstamar2015_13.jpg GRAPHIC 59206
16 vstamar2015_14.jpg GRAPHIC 57315
17 vstamar2015_15.jpg GRAPHIC 61652
18 vstamar2015_16.jpg GRAPHIC 58114
19 vstamar2015_17.jpg GRAPHIC 48557
20 vstamar2015_18.jpg GRAPHIC 56489
  Complete submission text file 0001415889-15-000913.txt   1496419
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54014 | Film No.: 15701721
SIC: 2834 Pharmaceutical Preparations